TTPA
Basic information
Region (hg38): 8:63048553-63086053
Previous symbols: [ "AVED" ]
Links
Phenotypes
GenCC
Source:
- familial isolated deficiency of vitamin E (Definitive), mode of inheritance: AR
- familial isolated deficiency of vitamin E (Strong), mode of inheritance: AR
- familial isolated deficiency of vitamin E (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ataxia with vitamin E deficiency | AR | Gastrointestinal | Preventive treatment with vitamin E administration can ameliorate signs and symptoms of disease; Untreated, individuals typically present with neurological manifestations, including progressive ataxia, and knowledge can allow early treatment (which involves chronic supplementation with high-dose oral vitamin E, with the goal of maintaining plasma vitamin E concentrations in the high-normal range) | Gastrointestinal; Neurologic | 4000224; 3361234; 7887897; 7719340; 8602747; 8972536; 463307; 10552255; 11554913; 12039660; 15300460; 20301419; 34663645 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (30 variants)
- Familial isolated deficiency of vitamin E (6 variants)
- Ataxia, Friedreich-like, with isolated vitamin E deficiency (2 variants)
- Retinal dystrophy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TTPA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 129 | 133 | ||||
missense | 102 | 106 | ||||
nonsense | 17 | |||||
start loss | 3 | |||||
frameshift | 18 | 23 | 41 | |||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 11 | 15 | ||||
splice region | 1 | 3 | 6 | 3 | 13 | |
non coding | 37 | 42 | 15 | 94 | ||
Total | 31 | 48 | 142 | 171 | 18 |
Highest pathogenic variant AF is 0.0000920
Variants in TTPA
This is a list of pathogenic ClinVar variants found in the TTPA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-63059536-A-G | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 12, 2018) | ||
8-63059654-G-A | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 12, 2018) | ||
8-63059765-C-T | Familial isolated deficiency of vitamin E | Benign (Jan 13, 2018) | ||
8-63059766-G-A | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 13, 2018) | ||
8-63059767-GTTAT-G | Familial isolated deficiency of vitamin E | Uncertain significance (Jun 14, 2016) | ||
8-63059811-G-C | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 13, 2018) | ||
8-63059828-G-A | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 13, 2018) | ||
8-63059830-A-C | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 13, 2018) | ||
8-63059845-C-T | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 12, 2018) | ||
8-63059848-C-T | Familial isolated deficiency of vitamin E | Benign (Jan 13, 2018) | ||
8-63059858-T-C | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 12, 2018) | ||
8-63059884-G-C | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 12, 2018) | ||
8-63059887-T-G | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 13, 2018) | ||
8-63060005-T-C | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 13, 2018) | ||
8-63060070-ATAT-A | Familial isolated deficiency of vitamin E | Uncertain significance (Jun 14, 2016) | ||
8-63060088-T-A | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 13, 2018) | ||
8-63060117-A-G | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 12, 2018) | ||
8-63060159-C-T | Familial isolated deficiency of vitamin E | Benign (Jan 12, 2018) | ||
8-63060318-G-A | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 13, 2018) | ||
8-63060320-C-T | Familial isolated deficiency of vitamin E | Likely benign (Jan 13, 2018) | ||
8-63060435-C-T | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 13, 2018) | ||
8-63060446-G-A | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 13, 2018) | ||
8-63060470-G-A | Familial isolated deficiency of vitamin E | Benign (Jan 13, 2018) | ||
8-63060476-G-A | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 13, 2018) | ||
8-63060483-C-T | Familial isolated deficiency of vitamin E | Uncertain significance (Jan 12, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TTPA | protein_coding | protein_coding | ENST00000260116 | 5 | 37501 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00144 | 0.882 | 125662 | 0 | 78 | 125740 | 0.000310 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.303 | 135 | 145 | 0.929 | 0.00000730 | 1800 |
Missense in Polyphen | 49 | 52.808 | 0.92789 | 660 | ||
Synonymous | -0.142 | 56 | 54.7 | 1.02 | 0.00000267 | 547 |
Loss of Function | 1.36 | 6 | 10.8 | 0.553 | 5.25e-7 | 127 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000410 | 0.000410 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000510 | 0.000510 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Binds alpha-tocopherol, enhances its transfer between separate membranes, and stimulates its release from liver cells (PubMed:7887897). Binds both phosphatidylinol 3,4-bisphosphate and phosphatidylinol 4,5-bisphosphate; the resulting conformation change is important for the release of the bound alpha-tocopherol (By similarity). {ECO:0000250, ECO:0000269|PubMed:7887897}.;
- Disease
- DISEASE: Ataxia with isolated vitamin E deficiency (AVED) [MIM:277460]: An autosomal recessive disease characterized by undetectable or markedly reduced plasma levels of vitamin E, spinocerebellar degeneration, ataxia, areflexia and proprioception loss. {ECO:0000269|PubMed:15065857, ECO:0000269|PubMed:15300460, ECO:0000269|PubMed:7566022, ECO:0000269|PubMed:8602747, ECO:0000269|PubMed:9463307}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Metabolism of fat-soluble vitamins;Metabolism;Metabolism of vitamins and cofactors;Vitamin E
(Consensus)
Recessive Scores
- pRec
- 0.589
Intolerance Scores
- loftool
- 0.478
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.25
Haploinsufficiency Scores
- pHI
- 0.179
- hipred
- N
- hipred_score
- 0.444
- ghis
- 0.505
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.711
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ttpa
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; muscle phenotype;
Zebrafish Information Network
- Gene name
- ttpa
- Affected structure
- immature eye
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- embryonic placenta development;lipid metabolic process;response to nutrient;response to pH;response to toxic substance;vitamin E metabolic process;vitamin transport;intracellular pH reduction;negative regulation of cell death;negative regulation of establishment of blood-brain barrier;intermembrane lipid transfer
- Cellular component
- late endosome;cytosol
- Molecular function
- protein binding;phosphatidylinositol-4,5-bisphosphate binding;vitamin E binding;phosphatidylinositol-3,4-bisphosphate binding;intermembrane lipid transfer activity